PRKAA2 and steatosis: AMPK activation promotes lipid oxidation and reduces steatosis, whereas ceramide accumulation, especially from saturated fats, impairs AMPK phosphorylation, drives insulin resistance, and contributes to metabolic dysfunction (15, 16).